Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
Department of Medicine/Pediatrics, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
J Clin Invest. 2018 Aug 1;128(8):3583-3594. doi: 10.1172/JCI120972. Epub 2018 Jul 23.
T cells must migrate in order to encounter antigen-presenting cells (APCs) and to execute their varied functions in immune defense and inflammation. ATP release and autocrine signaling through purinergic receptors contribute to T cell activation at the immune synapse that T cells form with APCs. Here, we show that T cells also require ATP release and purinergic signaling for their migration to APCs. We found that the chemokine stromal-derived factor-1α (SDF-1α) triggered mitochondrial ATP production, rapid bursts of ATP release, and increased migration of primary human CD4+ T cells. This process depended on pannexin-1 ATP release channels and autocrine stimulation of P2X4 receptors. SDF-1α stimulation caused localized accumulation of mitochondria with P2X4 receptors near the front of cells, resulting in a feed-forward signaling mechanism that promotes cellular Ca2+ influx and sustains mitochondrial ATP synthesis at levels needed for pseudopod protrusion, T cell polarization, and cell migration. Inhibition of P2X4 receptors blocked the activation and migration of T cells in vitro. In a mouse lung transplant model, P2X4 receptor antagonist treatment prevented the recruitment of T cells into allograft tissue and the rejection of lung transplants. Our findings suggest that P2X4 receptors are therapeutic targets for immunomodulation in transplantation and inflammatory diseases.
T 细胞必须迁移才能与抗原呈递细胞 (APCs) 相遇,并在免疫防御和炎症中执行其多样化的功能。ATP 的释放和嘌呤能受体的自分泌信号转导有助于 T 细胞在与 APC 形成的免疫突触中被激活。在这里,我们表明 T 细胞也需要 ATP 释放和嘌呤能信号转导才能迁移到 APC。我们发现趋化因子基质衍生因子-1α (SDF-1α) 触发了线粒体 ATP 的产生、ATP 的快速释放以及原代人 CD4+T 细胞的迁移增加。这个过程依赖于连接蛋白-1 (pannexin-1) 的 ATP 释放通道和 P2X4 受体的自分泌刺激。SDF-1α 刺激导致 P2X4 受体附近的线粒体在细胞前缘局部积聚,从而形成一个正反馈信号机制,促进细胞内 Ca2+内流,并维持线粒体 ATP 合成,以满足伪足伸出、T 细胞极化和细胞迁移所需的水平。P2X4 受体抑制剂可阻断 T 细胞在体外的激活和迁移。在小鼠肺移植模型中,P2X4 受体拮抗剂治疗可防止 T 细胞募集到同种异体组织并防止肺移植排斥。我们的研究结果表明,P2X4 受体是移植和炎症性疾病免疫调节的治疗靶点。
J Clin Invest. 2018-7-23
J Leukoc Biol. 2012-6-29
Front Immunol. 2020-9-29
NeuroImmune Pharm Ther. 2025-5-23
Contact (Thousand Oaks). 2025-4-13
J Endocrinol Invest. 2025-2
Trends Immunol. 2024-11
Ann Am Thorac Soc. 2017-9
PLoS Comput Biol. 2016-3-18
Nat Rev Immunol. 2016-3
Nat Rev Immunol. 2016-3
Neuropharmacology. 2016-5
Neuropharmacology. 2016-5
J Cell Biol. 2015-9-28